Surgical Division is global leader in surgical laser technology and medical laser equipment, and considered a pioneer in the field of laser for surgery
X
GO
Surgical News

Lumenis to Highlight the Positive Impact of its FiberLase™ CO2 Laser Treatment for Ovarian Endometrioma on Ovarian Reserve

Presenters will feature results of recent successful studies using the innovative technology and its unique operative technique.

October 18th, 2017 – Yokneam, Israel.

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced today that it will share new clinical data on its CO2 laser-based FiberLase™ for minimally-invasive treatment of endometriosis at the European Society for Gynecological Endoscopy (ESGE) 26th Annual Congress, October 18- 21 at the Sueno Hotel Belek & Convention Center in Antalya, Turkey.

Lumenis Launches Its New Moses™ Holmium Technology in the American Urological Association Annual Meeting

Revolutionizing stone fragmentation and stone dusting

May 12th, 2017 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced the launch of its new Moses™ Holmium technology during the 112th American Urological Association (AUA) annual meeting in Boston. The AUA launch of Moses follows a successful introduction of the technology during the last European Association of Urologists (EAU) annual congress in London, where hundreds of physicians had a firsthand experience of the Moses technology – stressing its truly innovative nature and potential to revolutionize the world of holmium laser lithotripsy.

Dedicated to Women’s Health Lumenis Announces Support of Fourth Annual Worldwide Endometriosis March

Improving public awareness of this high prevalent disease may help women by encouraging earlier diagnosis and proper treatment.

March 24, 2017 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced today their support of the fourth annual Worldwide Endometriosis March (EndoMarch), an international event bringing together women and supporters to raise awareness of endometriosis. This year’s EndoMarch will be celebrated on Saturday, March 25, 2017, while the entire month of March is dedicated to awareness efforts and empowering women with education and knowledge.

PB-2008091 Rev A

Lumenis Unveils its new Moses™ Technology at European Association of Urology Annual Congress

A revolution in urological holmium lasers and fibers

March 22, 2017 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the upcoming launch of its new Moses™ holmium technology in a range of launch events at the 32nd annual European Association of Urology (EAU) Congress, taking place in London from March 24-27, 2017.

Lumenis Announces Support of Successful Health Mission to Provide Medical Treatment to Underserved Population

Collaboration with Haiti Mission Project Positively Impacts Local Community

March 15, 2017 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced successful outcomes directly tied to their support of Global, Surgical, Destination, Healthcare (GSD) Inc.‘s Medical Mission to Haiti. As a result of the mission, the fifth of its kind, over one hundred patients were seen and treated during the course of the six-day visit, which included 50 surgeries.

PB-2008054 Rev. A

Lumenis Advances Endometriosis Therapy and Awareness

Providing Gynecologists and their Patients True Added Value with a Delicate and Precise Surgical Tool and a New Online Resource for Patient Education and Support

November 14, 2016 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications articulates its commitment to providing gynecologists with a flexible CO2 laser solution designed for minimally invasive surgical approach to effectively and delicately remove endometriosis lesions while protecting valuable surrounding healthy tissue and preserving its functionality. Focusing on gynecological health and addressing various indications, Lumenis will showcase its 360° approach to gynecology and innovative CO2 laser portfolio at the American Association of Gynecologic Laparoscopists (AAGL) Annual Meeting, taking place November 14-18, 2016 in Orlando, Florida.

PB-2007295 rev A

A New Solution for Delicate and Precise Middle Ear Surgery: Delivering Optimal Laser Performance with OtoLase™

As an Innovative Leader in ENT, Lumenis Promotes Fiber-based Solutions to Enable Physicians Unlimited Flexibility and a Whole New Sphere of Improved Patient Care

September 16, 2016 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the introduction of OtoLase™, the new otology designated enhancement for the AcuPulse™ family of products. Specifically designed for enhanced precision and ease of use in middle ear surgery, the innovative OtoLase will be showcased at the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual meeting 2016, being held in San Diego on September 18-21, 2016.

PB-2007294 rev A

RSS
12345

Keep Me Updated

PB-1004683 A

Get More Info

For further information:

Cassandra Dump,
Pascale Communications
619.971.1887
Email: Cassy@pascalecommunications.com